US EditionMcDonald’s Sales and Profit Falls After 2024 E. Coli Outbreak
- McDonald's launched a new value menu in January 2025 to revive sales after several poor quarters and a sharp drop in customer visits.
- The value menu followed a downturn caused by a U.S. E. coli outbreak last fall that sickened over 100 people and hurt the brand's value perception.
- Fourth-Quarter U.S. sales fell 1.4%, reversing a 4.3% gain from the previous year, while McDonald's invested $100 million in marketing and plans 2,200 new global restaurants in 2025.
- CEO Chris Kempczinski said 2024 results did not meet expectations, and analysts warn that GLP-1 weight-loss drugs could reduce fast-food demand long term.
- Sales bottomed out in November after the outbreak ended, with recovery expected in early 2025, but new consumer habits and price pressures challenge McDonald's growth prospects.
Insights by Ground AI
Does this summary seem wrong?
10 Articles
10 Articles
All
Left
1
Center
4
Right
1
McDonald’s Shares Slump as GLP-1 Risks Spur Rare Sell Rating
McDonald’s Corp. shares slumped on Tuesday after Redburn Atlantic slapped the burger chain with its sole sell rating, saying shifting consumer patterns due to weight-loss drugs and inflation are cause for concern.
·United States
Read Full Article
22:27 Investors were cautiously optimistic about the trade talks between China and the United States. McDonald's traded at a loss after a very rare sell recommendation.
·Belgium
Read Full ArticleCoverage Details
Total News Sources10
Leaning Left1Leaning Right1Center4Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 17%
C 67%
R 17%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
